Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Roger

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Toxicon : Official Journal of the International Society on Toxinology|May 28, 2013
The rat Digit Abduction Score (DAS) assay: a physiological model for assessing botulinum neurotoxin-induced skeletal muscle paralysisRon S Broide, John Rubino, Gregory S Nicholson, et al.
Social Science & Medicine (1982)|January 19, 2021
Healing journeys: Indigenous Men's reflections on resources and barriers to mental wellnessC M Waddell, M D de Jager, J Gobeil, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 17, 2009
Activation of TRPV1 mediates calcitonin gene-related peptide release, which excites trigeminal sensory neurons and is attenuated by a retargeted botulinum toxin with anti-nociceptive potentialJianghui Meng, Saak V Ovsepian, Jiafu Wang, et al.
Nature Clinical Practice. Urology|May 8, 2008
Drug Insight: biological effects of botulinum toxin A in the lower urinary tractMichael B Chancellor, Clare J Fowler, Apostolos Apostolidis, et al.
Neurochemistry International|January 12, 2008
Botulinum toxin type A normalizes alterations in urothelial ATP and NO release induced by chronic spinal cord injuryChristopher P Smith, David A Gangitano, Alvaro Munoz, et al.
Toxicon : Official Journal of the International Society on Toxinology|October 8, 2003
Intramuscular injection of 125I-botulinum neurotoxin-complex versus 125I-botulinum-free neurotoxin: time course of tissue distributionDiane D-S Tang-Liu, K Roger Aoki, J Oliver Dolly, et al.
The Journal of Biological Chemistry|October 17, 2002
Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neuronsPatrick G Foran, Nadiem Mohammed, Godfrey O Lisk, et al.
Analytical Biochemistry|February 9, 2011
Depolarization after resonance energy transfer (DARET): a sensitive fluorescence-based assay for botulinum neurotoxin protease activityMarcella A Gilmore, Dudley Williams, Yumiko Okawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2004
Plasma membrane localization signals in the light chain of botulinum neurotoxinEster Fernández-Salas, Lance E Steward, Helen Ho, et al.
Archives of Otolaryngology--Head & Neck Surgery|July 18, 2012
Transoral robotic surgery alone for oropharyngeal cancer: an analysis of local controlGregory S Weinstein, Harry Quon, H Jason Newman, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Toxicon : Official Journal of the International Society on Toxinology|May 28, 2013
The rat Digit Abduction Score (DAS) assay: a physiological model for assessing botulinum neurotoxin-induced skeletal muscle paralysisRon S Broide, John Rubino, Gregory S Nicholson, et al.
Social Science & Medicine (1982)|January 19, 2021
Healing journeys: Indigenous Men's reflections on resources and barriers to mental wellnessC M Waddell, M D de Jager, J Gobeil, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 17, 2009
Activation of TRPV1 mediates calcitonin gene-related peptide release, which excites trigeminal sensory neurons and is attenuated by a retargeted botulinum toxin with anti-nociceptive potentialJianghui Meng, Saak V Ovsepian, Jiafu Wang, et al.
Nature Clinical Practice. Urology|May 8, 2008
Drug Insight: biological effects of botulinum toxin A in the lower urinary tractMichael B Chancellor, Clare J Fowler, Apostolos Apostolidis, et al.
Neurochemistry International|January 12, 2008
Botulinum toxin type A normalizes alterations in urothelial ATP and NO release induced by chronic spinal cord injuryChristopher P Smith, David A Gangitano, Alvaro Munoz, et al.
Toxicon : Official Journal of the International Society on Toxinology|October 8, 2003
Intramuscular injection of 125I-botulinum neurotoxin-complex versus 125I-botulinum-free neurotoxin: time course of tissue distributionDiane D-S Tang-Liu, K Roger Aoki, J Oliver Dolly, et al.
The Journal of Biological Chemistry|October 17, 2002
Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neuronsPatrick G Foran, Nadiem Mohammed, Godfrey O Lisk, et al.
Analytical Biochemistry|February 9, 2011
Depolarization after resonance energy transfer (DARET): a sensitive fluorescence-based assay for botulinum neurotoxin protease activityMarcella A Gilmore, Dudley Williams, Yumiko Okawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2004
Plasma membrane localization signals in the light chain of botulinum neurotoxinEster Fernández-Salas, Lance E Steward, Helen Ho, et al.
Archives of Otolaryngology--Head & Neck Surgery|July 18, 2012
Transoral robotic surgery alone for oropharyngeal cancer: an analysis of local controlGregory S Weinstein, Harry Quon, H Jason Newman, et al.
Pageof 8